Astera Labs, Inc. $ALAB Shares Sold by Royal Bank of Canada

Royal Bank of Canada reduced its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 21.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 132,292 shares of the company’s stock after selling 36,506 shares during the period. Royal Bank of Canada owned approximately 0.08% of Astera Labs worth $14,499,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of ALAB. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs in the 4th quarter worth approximately $18,708,000. Swedbank AB lifted its position in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of Astera Labs during the fourth quarter worth $499,000. Revere Asset Management Inc purchased a new position in shares of Astera Labs in the fourth quarter valued at $589,000. Finally, Banque Cantonale Vaudoise grew its holdings in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after purchasing an additional 3,229 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ALAB. JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Jefferies Financial Group raised their price objective on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday. Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Finally, TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

Astera Labs Stock Up 0.8%

ALAB opened at $334.17 on Friday. The company’s 50-day moving average price is $360.45 and its 200 day moving average price is $235.27. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The firm has a market cap of $57.98 billion, a price-to-earnings ratio of 165.43, a price-to-earnings-growth ratio of 3.84 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the business posted $0.44 EPS. The business’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 14,076 shares of the company’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the completion of the transaction, the general counsel owned 104,139 shares in the company, valued at approximately $24,137,337.42. This represents a 11.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,244,395 shares of company stock valued at $358,865,571. Company insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.